Astellas Pharma (Germany) Alpha and Beta Analysis

YPH Stock  EUR 9.50  0.20  2.15%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Astellas Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Astellas Pharma over a specified time horizon. Remember, high Astellas Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Astellas Pharma's market risk premium analysis include:
Beta
(0.32)
Alpha
(0.16)
Risk
2.2
Sharpe Ratio
(0.08)
Expected Return
(0.18)
Please note that although Astellas Pharma alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Astellas Pharma did 0.16  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Astellas Pharma stock's relative risk over its benchmark. Astellas Pharma has a beta of 0.32  . As returns on the market increase, returns on owning Astellas Pharma are expected to decrease at a much lower rate. During the bear market, Astellas Pharma is likely to outperform the market. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Astellas Pharma Backtesting, Astellas Pharma Valuation, Astellas Pharma Correlation, Astellas Pharma Hype Analysis, Astellas Pharma Volatility, Astellas Pharma History and analyze Astellas Pharma Performance.

Astellas Pharma Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Astellas Pharma market risk premium is the additional return an investor will receive from holding Astellas Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Astellas Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Astellas Pharma's performance over market.
α-0.16   β-0.32

Astellas Pharma expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Astellas Pharma's Buy-and-hold return. Our buy-and-hold chart shows how Astellas Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Astellas Pharma Market Price Analysis

Market price analysis indicators help investors to evaluate how Astellas Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Astellas Pharma shares will generate the highest return on investment. By understating and applying Astellas Pharma stock market price indicators, traders can identify Astellas Pharma position entry and exit signals to maximize returns.

Astellas Pharma Return and Market Media

The median price of Astellas Pharma for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 is 10.47 with a coefficient of variation of 4.12. The daily time series for the period is distributed with a sample standard deviation of 0.43, arithmetic mean of 10.45, and mean deviation of 0.32. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About Astellas Pharma Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Astellas or other stocks. Alpha measures the amount that position in Astellas Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Astellas Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Astellas Pharma's short interest history, or implied volatility extrapolated from Astellas Pharma options trading.

Build Portfolio with Astellas Pharma

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Other Information on Investing in Astellas Stock

Astellas Pharma financial ratios help investors to determine whether Astellas Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Astellas with respect to the benefits of owning Astellas Pharma security.